iShares Biotechnology ETF (IBB) is a publicly traded company in the Financial Services sector, operating within the Asset Management industry. The company is headquartered in San Francisco, DE, United States.
IBB has IPO date of 2001-02-12, listed on the NASDAQ Global Market, a market capitalization of $8.48B.
The iShares Biotechnology ETF is a non-diversified fund that allocates at least 80% of its assets to biotechnology companies and securities that mirror its underlying index. The fund may invest up to 20% of its assets in derivatives including futures, options, and swap contracts, along with cash and cash equivalents, to achieve its investment objectives. As a passively managed exchange-traded fund, it provides investors with broad exposure to the biotechnology sector through a single, liquid investment vehicle.
